c-Fos mediates α1, 2-fucosyltransferase 1 and Lewis y expression in response to TGF-β1 in ovarian cancer

被引:17
|
作者
Hao, Yingying [1 ]
Zhu, Liancheng [1 ]
Yan, Limei [1 ]
Liu, Juanjuan [1 ]
Liu, Dawo [1 ]
Gao, Na [2 ]
Tan, Mingzi [1 ]
Gao, Song [1 ]
Lin, Bei [1 ]
机构
[1] China Med Univ, Dept Obstet & Gynecol, Shengjing Hosp, 36 Sanhao St, Shenyang 110004, Liaoning, Peoples R China
[2] Dalian Med Univ, Dept Obstet & Gynecol, Affiliated Hosp 1, Dalian 116011, Liaoning, Peoples R China
基金
中国国家自然科学基金;
关键词
TGF-beta; 1; c-Fos; MAPK; alpha; 2-fucosyltransferase; Lewis y; ovarian cancer; TRANSCRIPTION FACTOR AP-1; BLOOD GROUP ANTIGEN; GROWTH-FACTOR-BETA; CELL-PROLIFERATION; TRANSFORMING GROWTH-FACTOR-BETA-1; HEPATOCELLULAR-CARCINOMA; SUPPRESSION; ACTIVATION; SURVIVAL; PROGRESSION;
D O I
10.3892/or.2017.6052
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
FUT1 is a key rate-limiting enzyme in the synthesis of Lewis y, a membrane-associated carbohydrate antigen. The aberrant upregulation of FUT1 and Lewis y antigen is related to proliferation, invasion and prognosis in malignant epithelial tumors. A c-Fos/activator protein-1 (AP-1) binding site was found in the FUT1 promoter. However, the mechanisms of transcriptional regulation of FUT1 remain poorly understood. TGF-beta 1 is positively correlated to Lewis y. In the present study, we investigated the molecular mechanism of FUT1 gene expression in response to TGF-beta 1. We demonstrated that c-Fos was highly expressed in 77.50% of ovarian epithelial carcinoma cases and was significantly correlated with Lewis y. Using luciferase activity and chromatin immunoprecipitation (ChIP) assay, we further revealed that c-Fos interacted with the FUT1 promoter in ovarian cancer cells and transcriptional capacity of the heterodimer formed by c-Fos and c-Jun was stronger than that of the c-Fos or c-Jun homodimers. Then, we demonstrated that TGF-beta 1 induced dose-dependent c-Fos expression, which was involved in TGF-beta 1-induced ovarian cancer cell proliferation. In addition, inhibition of MAPK activation or TGF-beta 1 receptor by pharmacological agents prevented TGF-beta 1-induced c-Fos and Lewis y expression. Silencing of c-Fos prevented TGF-beta 1-induced Lewis y expression. Collectively, the results of these studies demonstrated that TGF-beta(1) regulated FUT1 and Lewis y expression by activating the MAPK/c-Fos pathway.
引用
收藏
页码:3355 / 3366
页数:12
相关论文
共 50 条
  • [21] LncRNA HOTAIR down-expression inhibits the invasion and tumorigenicity of epithelial ovarian cancer cells by suppressing TGF-β1 and ZEB1
    Zhou, Yufu
    Zhang, Yunjie
    Shao, Yidan
    Yue, Xiaoli
    Chu, Yifan
    Yang, Cuiping
    Chen, Dengyu
    DISCOVER ONCOLOGY, 2023, 14 (01)
  • [22] Oxidative stress mediates the conversion of endothelial cells into myofibroblasts via a TGF-β1 and TGF-β2-dependent pathway
    Montorfano, Ignacio
    Becerra, Alvaro
    Cerro, Roberto
    Echeverria, Cesar
    Saez, Elizabeth
    Gabriela Morales, Maria
    Fernandez, Ricardo
    Cabello-Verrugio, Claudio
    Simon, Felipe
    LABORATORY INVESTIGATION, 2014, 94 (10) : 1068 - 1082
  • [23] TGF-β1 induces HMGA1 expression: The role of HMGA1 in thyroid cancer proliferation and invasion
    Zhong, Jing
    Liu, Chang
    Zhang, Qing-Hai
    Chen, Ling
    Shen, Ying-Ying
    Chen, Ya-Jun
    Zeng, Xi
    Zu, Xu-Yu
    Cao, Ren-Xian
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2017, 50 (05) : 1567 - 1578
  • [24] CLIC4 mediates TGF-β1-induced fibroblast-to-myofibroblast transdifferentiation in ovarian cancer
    Yao, Qin
    Qu, Xun
    Yang, Qifeng
    Wei, Mingqian
    Kong, Beihua
    ONCOLOGY REPORTS, 2009, 22 (03) : 541 - 548
  • [25] Cervical cancer cells produce TGF-β1 through the CD73-adenosine pathway and maintain CD73 expression through the autocrine activity of TGF-β1
    Garcia-Rocha, Rosario
    Monroy-Garcia, Alberto
    Hernandez-Montes, Jorge
    Weiss-Steider, Benny
    Gutierrez-Serrano, Vianey
    del Carmen Fuentes-Castaneda, Maria
    Roberto Avila-Ibarra, Luis
    Azucena Don-Lopez, Christian
    Berenice Torres-Pineda, Daniela
    de Lourdes Mora-Garcia, Maria
    CYTOKINE, 2019, 118 : 71 - 79
  • [26] TGF-β1 induces HMGA1 expression in human breast cancer cells: Implications of the involvement of HMGA1 in TGF-β signaling
    Zu, Xuyu
    Zhong, Jing
    Tan, Jingjing
    Tan, Li
    Yang, Dong
    Zhang, Qinghai
    Ding, Wenjun
    Liu, Wen
    Wen, Gebo
    Liu, Jianghua
    Cao, Renxian
    Jiang, Yuyang
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2015, 35 (03) : 693 - 701
  • [27] NR2F1 Regulates TGF-β1-Mediated Epithelial-Mesenchymal Transition Affecting Platinum Sensitivity and Immune Response in Ovarian Cancer
    Liang, Qiuju
    Xu, Zhijie
    Liu, Yuanhong
    Peng, Bi
    Cai, Yuan
    Liu, Wei
    Yan, Yuanliang
    CANCERS, 2022, 14 (19)
  • [28] c-FOS is an integral component of the IKZF1 transactivator complex and mediates lenalidomide resistance in multiple myeloma
    Osada, Naoki
    Kikuchi, Jiro
    Iha, Hidekatsu
    Yasui, Hiroshi
    Ikeda, Sho
    Takahashi, Naoto
    Furukawa, Yusuke
    CLINICAL AND TRANSLATIONAL MEDICINE, 2023, 13 (08):
  • [29] Plasminogen/plasmin regulates c-fos and egr-1 expression via the MEWERK pathway
    De Sousa, LP
    Brasil, BSAF
    Silva, BM
    Freitas, MHA
    Nogueira, SV
    Ferreira, PCB
    Kroon, EG
    Bonjardim, CA
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 329 (01) : 237 - 245
  • [30] Enhanced FHL2 and TGF-β1 Expression Is Associated With Invasive Growth and Poor Survival in Malignant Melanomas
    Westphal, Philipp
    Mauch, Cornelia
    Florin, Alexandra
    Czerwitzki, Jacqueline
    Olligschlaeger, Nina
    Wodtke, Claudia
    Schuele, Roland
    Buettner, Reinhard
    Friedrichs, Nicolaus
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 143 (02) : 248 - 256